Corporate Fact Sheet
Who We Are
Advanced BioHealing, Inc. (ABH) is a leader in commercializing the promise of regenerative medicine. The Company develops and commercializes living cell therapies that repair damaged human tissue and enable the body to heal itself. ABH currently manufactures and markets Dermagraft®, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body’s natural healing process. Dermagraft is FDA approved to treat diabetic foot ulcers and is the focus of an ongoing pivotal trial to assess the product’s safety and efficacy in the promotion of healing venous leg ulcers.